CFO
ALAB icon

CVA Family Office’s Astera Labs ALAB Stock Holding History

CVA Family Office’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.7K Buy
49
+17
+53% +$4.51K ﹤0.01% 774
2026
Q1 		$3.51K Buy
32
+2
+7% +$285 ﹤0.01% 1360
2025
Q4 		$4.99K Buy
30
+13
+76% +$2.17K ﹤0.01% 887
2025
Q3 		$3.33K Buy
17
+3
+21% +$493 ﹤0.01% 941
2025
Q2 		$1.27K Sell
14
-16
-53% -$1.26K ﹤0.01% 1051
2025
Q1 		$1.79K Buy
+30
New +$2.77K ﹤0.01% 1025

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CVA Family Office's ALAB Position: Q2 2026 in Review

CVA Family Office increased its Astera Labs (ALAB) stake by 53% in Q2 2026, buying an estimated $4.51K and bringing the position to 49 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #774.

CVA Family Office first reported a position in ALAB in Q1 2025 and has held it in 6 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • CVA Family Office held 49 shares of Astera Labs worth $23.7K as of Q2 2026.
  • CVA Family Office bought 17 Astera Labs shares in Q2 2026, an estimated $4.51K.
  • Astera Labs made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #774 holding.
  • CVA Family Office first reported a position in Astera Labs in Q1 2025 and has held it in 6 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.